CIK 0001520262 · Large accelerated filer
Alkermes plc.
Sign in to watch- Ticker
- ALKS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981007018
- Phone
- 00-353-1-772-8000
- Business address
- CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
- Former names
- ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,070,874
- in 5 filings, $1.1M under 10b5-1 plans
Net −$1,070,874. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-23 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Grant or award · Restricted Stock Unit Award | +30,154 | 30,154 | ||
| 2023-02-23 | Brown Iain Michael SVP, Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +91,375 | 91,375 | ||
| 2023-02-23 | Brown Iain Michael SVP, Chief Financial Officer | Grant or award · Restricted Stock Unit Award | +22,844 | 22,844 | ||
| 2023-02-22 | Nichols Christian Todd SVP, Chief Commercial Officer | Option exercise | +6,969 | 51,188 | ||
| 2023-02-22 | Nichols Christian Todd SVP, Chief Commercial Officer | Shares withheld for taxes | −2,704 | $27.77 | $75K | 48,484 |
| 2023-02-22 | Nichols Christian Todd SVP, Chief Commercial Officer | Option exercise · Restricted Stock Unit Award | −6,969 | 13,939 | ||
| 2023-02-22 | LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. | Option exercise | +5,544 | 252,904 | ||
| 2023-02-22 | LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. | Shares withheld for taxes | −2,462 | $27.77 | $68K | 250,442 |
| 2023-02-22 | LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. | Option exercise · Restricted Stock Unit Award | −5,544 | 11,088 | ||
| 2023-02-22 | Jackson Blair Curtis EVP, Chief Operating Officer | Option exercise | +9,504 | 117,205 | ||
| 2023-02-22 | Jackson Blair Curtis EVP, Chief Operating Officer | Shares withheld for taxes | −3,088 | $27.77 | $86K | 114,117 |
| 2023-02-22 | Jackson Blair Curtis EVP, Chief Operating Officer | Option exercise · Restricted Stock Unit Award | −9,504 | 19,007 | ||
| 2023-02-22 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Option exercise | +12,038 | 61,904 | ||
| 2023-02-22 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Shares withheld for taxes | −5,345 | $27.77 | $148K | 56,559 |
| 2023-02-22 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Option exercise · Restricted Stock Unit Award | −12,038 | 24,076 | ||
| 2023-02-22 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Option exercise | +7,286 | 130,077 | ||
| 2023-02-22 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Shares withheld for taxes | −3,224 | $27.77 | $90K | 126,853 |
| 2023-02-22 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Option exercise · Restricted Stock Unit Award | −7,286 | 14,572 | ||
| 2023-02-22 | Brown Iain Michael SVP, Chief Financial Officer | Option exercise | +6,969 | 84,887 | ||
| 2023-02-22 | Brown Iain Michael SVP, Chief Financial Officer | Shares withheld for taxes | −2,049 | $27.77 | $57K | 82,838 |
Page 43 of 60 · 1,194 trades